Marcelino Bermudez Lopez
Grau: Doctor/a
973702482
mbermudez(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/C-3787-2011
Publicacions
-
Teis, A; Castelblanco, E; Cediel, G; Amigó, N; Julve, J; Ribalta, J; Guardiola, M; Franch, J; Bermúdez-López, M; Codina, P; Lupón, J; Mauricio, D; Alonso, N; Bayés-Genís, A
1H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls
Revista espanola de cardiologia (English ed.) 75 864-873. .
-
GONZALEZ GUTIERREZ, JESSICA; GRACIA LAVEDAN, ESTHER; GÓMEZ FALGUERA, SILVIA; BARRIL FARRE, SILVIA; GODOY GARCIA, PERE; BERMUDEZ LOPEZ, MARCELINO; Betriu, Angels; Fernandez, Elvira; LECUBE TORELLÓ, ALBERT; PAMPLONA GRAS, REINALD; PURROY GARCIA, FRANCISCO; Farras Salles, Cristina; BARBÉ ILLA, FERRAN; TORRES CORTADA, GERARD; DE BATLLE GARCIA, JORDI
Lung Function Impairment Is Related to Subclinical Atherosclerosis Only in Active Smokers
Vasa-European Journal of Vascular Medicine -. .
-
Bermúdez-López M; Martí-Antonio M; Castro-Boqué E; Bretones MDM; Farràs C; Torres G; Pamplona R; Lecube A; Mauricio D; Valdivielso JM; Fernández E
Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study.
Frontiers in Cardiovascular Medicine 9 895917-895917. .
-
Sánchez E; Kerkeni M; Hernández M; Gavaldà R; Rius F; Sauret A; Torres G; Bermúdez-López M; Fernández E; Castro-Boqué E; Purroy F; Mauricio D; Farràs-Sallés C; Buti M; Godoy P; Pamplona R; Lecube A
Weak Association between Skin Autofluorescence Levels and Prediabetes with an ILERVAS Cross-Sectional Study.
Nutrients 14 -. .
-
Sanchez, E; Sapiña-Beltrán E; Gavalda, R; Barbe, F; Torres, G; Sauret, A; Dalmases, M; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Bermudez-Lopez, M; Fernandez, E; Purroy, F; Castro-Boque, E; Farràs-Sallés C; Pamplona, R; Mauricio, D; Hernandez, C; Simo, R; Lecube, A
Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing.
Journal of Clinical Medicine 11 -. .
-
Núñez E; Fuster, V; Gomez-Serrano, M; Valdivielso, JM; Fernandez-Alvira, JM; Martinez-Lopez, D; Rodriguez, JM; Bonzon-Kulichenko, E; Calvo, E; Alfayate, A; Bermudez-Lopez, M; Escola-Gil, JC; Fernandez-Friera, L; Cerro-Pardo, I; Mendiguren, JM; Sanchez-Cabo, F; Sanz, J; Ordovas, JM; Blanco-Colio, LM; Garcia-Ruiz, JM; Ibáñez B; Lara-Pezzi, E; Fernandez-Ortiz, A; Martin-Ventura, JL; Vazquez, J
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis.
EBioMedicine 76 103874-103874. .
-
Purroy F; Sánchez E; Lecube A; Arqué G; Vicente-Pascual M; Mauri-Capdevila G; Torreguitart N; Hernández M; Barbé F; Fernández E; Pamplona R; Farràs C; Mauricio D; Bermúdez-López M
Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project.
Frontiers in Neurology 12 785640-785640. .
-
Castelblanco E; Hernández M; Ortega E; Amigó N; Real J; Granado-Casas M; Miñambres I; Lopez C; Lecube A; Bermúdez-López M; Alonso N; Julve J; Mauricio D
Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control.
DIABETES RESEARCH AND CLINICAL PRACTICE 182 109145-109145. .
-
Bermudez-Lopez M; Perpiñan H; Amigo N; Castro E; Alonso N; Mauricio D; Fernandez E; Valdivielso JM
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.
CLINICAL KIDNEY JOURNAL 14 2591-2599. .
-
Bermúdez-López M; Martínez-Alonso M; Castro-Boqué E; Betriu À; Cambray S; Farràs C; Barbé F; Pamplona R; Lecube A; Mauricio D; Purroy F; Valdivielso JM; Fernández E; ILERVAS project collaborators
Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study.
Revista espanola de cardiologia (English ed.) 74 1042-1053. .
-
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Aging-US 13 22690-22709. .
-
Bozic, Milica; Diaz-Tocados, Juan M.; Bermudez-Lopez, Marcelino; Forne, Carles; Martinez, Cristina; Fernandez, Elvira; Valdivielso, Jose M.
Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.
NEPHROLOGY DIALYSIS TRANSPLANTATION 37 1-10. .
Projectes
- ANGEL: A machine learning algorithm to predict atherosclerotic cardiovascular disease.
- Development of dynamic models for the personalized prevention and treatment of age-related diseases
- Impacto del Manejo de los Trastornos Respiratorios Durante el Sueño en el control de la hipertensión sistémica: Proyecto METASLEEP
- Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
- Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
- Projecte d'Investigació ILERVAS - 2022
- Ayudas Juan de la Cierva - Incorporación 2018
- Projecte d'investigació ILERVAS -2020 Diputació
- Caracterización de un perfil lipidomico y lipídico de riesgo aterogénico y de morbimortalidad cardiovascular en la enfermedad renal crónica (estadios 3 a 5) (estudio prospectivo NEFRONA)
- AJUT PER A LA CONTRACTACIÓ D'UN NOU INVESTIGADOR
